title: Solid lipid nanoparticle-based calix[n]arenes and calix-resorcinarenes as building blocks: synthesis, formulation and characterization.
abstract: Solid lipid nanoparticles (SLNs) have attracted increasing attention during recent years. This paper presents an overview about the use of calix[n]arenes and calix-resorcinarenes in the formulation of SLNs. Because of their specific inclusion capability both in the intraparticle spaces and in the host cavities as well as their capacity for functionalization, these colloidal nanostructures represent excellent tools for the encapsulation of different active pharmaceutical ingredients (APIs) in the area of drug targeting, cosmetic additives, contrast agents, etc. Various synthetic routes to the supramolecular structures will be given. These various routes lead to the formulation of the corresponding SLNs. Characterization, properties, toxicological considerations as well as numerous corresponding experimental studies and analytical methods will be also exposed and discussed.
authors.affiliation: INRAP, Technopôle de Sidi Thabet, Sidi Thabet 2020, Tunisia. antony.coleman@adm.univ-lyon1.fr.
authors.forename: Imed
authors.initials: I
authors.lastname: Montasser
authors.forename: Patrick
authors.initials: P
authors.lastname: Shahgaldian
authors.forename: Florent
authors.initials: F
authors.lastname: Perret
authors.forename: Anthony W
authors.initials: AW
authors.lastname: Coleman
mesh_terms: D047250:Calixarenes / Q000737:chemistry*; D003102:Colloids / Q000737:chemistry; D004337:Drug Carriers / Q000008:administration & dosage; D016503:Drug Delivery Systems; D006801:Humans; D008055:Lipids / Q000008:administration & dosage / Q000737:chemistry*; D053758:Nanoparticles / Q000737:chemistry*
chemical_list: D003102:Colloids; D004337:Drug Carriers; D008055:Lipids; D047250:Calixarenes